Dashboard
Manage Tickers

CTSO Cytosorbents Corp

Nasdaq cytosorbents.com


$ 0.91 $ -0.01 (-1.49 %)    

Thursday, 16-Oct-2025 11:35:53 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 603.32 $ -1.97 (-0.33 %)
DIA $ 462.10 $ -1.27 (-0.27 %)
SPY $ 664.49 $ -2.40 (-0.36 %)
TLT $ 90.87 $ 0.37 (0.41 %)
GLD $ 393.50 $ 2.33 (0.6 %)
$ 0.916
$ 0.92
$ 0.91 x 1,100
$ 0.92 x 100
$ 0.91 - $ 0.92
$ 0.71 - $ 1.61
33,767
na
57.49M
$ 0.96
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-14-2025 03-31-2025 10-Q
3 03-31-2025 12-31-2024 10-K
4 11-07-2024 09-30-2024 10-Q
5 08-13-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 03-14-2024 12-31-2023 10-K
8 11-09-2023 09-30-2023 10-Q
9 08-01-2023 06-30-2023 10-Q
10 05-02-2023 03-31-2023 10-Q
11 03-09-2023 12-31-2022 10-K
12 11-03-2022 09-30-2022 10-Q
13 08-02-2022 06-30-2022 10-Q
14 05-03-2022 03-31-2022 10-Q
15 03-10-2022 12-31-2021 10-K
16 11-04-2021 09-30-2021 10-Q
17 08-03-2021 06-30-2021 10-Q
18 05-04-2021 03-31-2021 10-Q
19 03-09-2021 12-31-2020 10-K
20 11-04-2020 09-30-2020 10-Q
21 08-04-2020 06-30-2020 10-Q
22 05-05-2020 03-31-2020 10-Q
23 03-05-2020 12-31-2019 10-K
24 11-05-2019 09-30-2019 10-Q
25 08-06-2019 06-30-2019 10-Q
26 05-07-2019 03-31-2019 10-Q
27 03-07-2019 12-31-2018 10-K
28 11-06-2018 09-30-2018 10-Q
29 08-02-2018 06-30-2018 10-Q
30 05-08-2018 03-31-2018 10-Q
31 03-08-2018 12-31-2017 10-K
32 11-09-2017 09-30-2017 10-Q
33 08-07-2017 06-30-2017 10-Q
34 05-08-2017 03-31-2017 10-Q
35 03-03-2017 12-31-2016 10-K
36 11-07-2016 09-30-2016 10-Q
37 08-09-2016 06-30-2016 10-Q
38 05-09-2016 03-31-2016 10-Q
39 03-09-2016 12-31-2015 10-K
40 11-13-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

deep-dive-into-cytosorbents-stock-analyst-perspectives-5-ratings
Deep Dive Into CytoSorbents Stock: Analyst...
09/16/2025 14:01:44

d-boral-capital-maintains-buy-on-cytosorbents-maintains-10-price-target
D. Boral Capital Maintains Buy on CytoSorb...
09/16/2025 13:11:29

D. Boral Capital analyst Jason Kolbert maintains CytoSorbents (NASDAQ:CTSO) with a Buy and maintains $10 price target.

cytosorbents-to-refile-de-novo-application-for-drugsorb-atr-expects-fda-review-in-mid-2026
CytoSorbents To Refile De Novo Application...
09/16/2025 11:14:48

 CytoSorbents Corporation (NASDAQ:CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit an...

d-boral-capital-maintains-buy-on-cytosorbents-maintains-10-price-target
D. Boral Capital Maintains Buy on CytoSorb...
08/20/2025 13:16:00

D. Boral Capital analyst Jason Kolbert maintains CytoSorbents (NASDAQ:CTSO) with a Buy and maintains $10 price target.

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
08/20/2025 12:08:41

why-rocket-pharmaceuticals-shares-are-trading-higher-by-over-15-here-are-20-stocks-moving-premarket
Why Rocket Pharmaceuticals Shares Are Trad...
08/20/2025 11:24:03

cytosorbents-updates-fda-status-appeal-confirms-no-safety-issues-for-drugsorb-atr-but-upholds-de-novo-denial-fda-proposes-path-forward-for-market-authorization
CytoSorbents Updates FDA Status: Appeal Co...
08/20/2025 11:04:02

demystifying-cytosorbents-insights-from-5-analyst-reviews
Demystifying CytoSorbents: Insights From 5...
08/08/2025 13:02:13

d-boral-capital-maintains-buy-on-cytosorbents-maintains-10-price-target
D. Boral Capital Maintains Buy on CytoSorb...
08/08/2025 12:28:55

D. Boral Capital analyst Jason Kolbert maintains CytoSorbents (NASDAQ:CTSO) with a Buy and maintains $10 price target.

cytosorbents-q2-adj-eps-005-inline-sales-962m-miss-980m-estimate
CytoSorbents Q2 Adj. EPS $(0.05), Inline, ...
08/07/2025 20:13:44

CytoSorbents (NASDAQ:CTSO) reported quarterly losses of $(0.05) per share which met the analyst consensus estimate. This is a 3...

Core News & Articles
Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

a-glimpse-into-the-expert-outlook-on-cytosorbents-through-5-analysts
A Glimpse Into The Expert Outlook On CytoS...
07/21/2025 22:01:59

d-boral-capital-maintains-buy-on-cytosorbents-maintains-10-price-target
D. Boral Capital Maintains Buy on CytoSorb...
07/21/2025 17:28:27

D. Boral Capital analyst Jason Kolbert maintains CytoSorbents (NASDAQ:CTSO) with a Buy and maintains $10 price target.

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
07/02/2025 17:05:51

cytosorbents-pursues-supervisory-review-with-us-fda-and-reconsideration-with-health-canada-for-drugsorb-atr-marketing-applications
CytoSorbents Pursues Supervisory Review Wi...
07/02/2025 11:11:18

deep-dive-into-cytosorbents-stock-analyst-perspectives-6-ratings
Deep Dive Into CytoSorbents Stock: Analyst...
06/25/2025 13:00:16

d-boral-capital-maintains-buy-on-cytosorbents-maintains-10-price-target
D. Boral Capital Maintains Buy on CytoSorb...
06/25/2025 12:41:54

D. Boral Capital analyst Jason Kolbert maintains CytoSorbents (NASDAQ:CTSO) with a Buy and maintains $10 price target.

cytosorbents-files-request-for-supervisory-review-with-fda-of-de-novo-denial-letter-issued-for-cytosorbents-drugsorb-atr-device
CytoSorbents Files Request For Supervisory...
06/24/2025 11:10:51

CytoSorbents Corporation (NASDAQ:CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and...

cytosorbents-initiates-formal-appeal-to-fda-over-drugsorb-atr-denial-aiming-to-address-remaining-deficiencies
CytoSorbents Initiates Formal Appeal To FD...
06/24/2025 11:09:23

cytosorbents-presents-real-world-analysis-at-europcr-2025-showing-reduction-in-severe-bleeding-and-transfusion-needs-in-cabg-patients-on-blood-thinner-ticagrelor-with-cytosorbents-therapy
CytoSorbents Presents Real-World Analysis ...
05/22/2025 13:34:27

Real-World Analysis Shows Statistically Significant Reduction in Severe Bleeding and Transfusion Needs in CABG Patients on the ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION